Prof. Cecilia Gelfi is a Full Professor of Clinical Biochemistry and Molecular Biology at the Faculty of Medicine of the University of Milan. She received a degree in Pharmaceutical Science and Technologies from the Faculty of Pharmacy. She was a full member of the European Federation of the Laboratory Medicine Working Group on test evaluation in 2017 and a member of the Board of Directors of the Foundation Toscana Gabriele Monasterio for Medical Research and Public Health, based in Pisa, in 2012. Her research interests include the development of methodologies for the separation and identification of biomolecules, the investigation of the functional and morphological changes occurring in muscle in several physiological and pathological states, the development of (1) clinical methods for the monitoring of drugs; (2) protocols for serological profiles for the clinical diagnosis of pancreatic and prostate cancer; (3) MALDI imaging methodologies for monitoring nanoparticles; (4) HPTLC-MALDI methodologies for the recognition and quantitation of gangliosides and globosides in tissue extracts.
Prof. Cecilia Gelfi is a Full Professor of Clinical Biochemistry and Molecular Biology at the Faculty of Medicine of the University of Milan. She received a degree in Pharmaceutical Science and Technologies from the Faculty of Pharmacy. She was a full member of the European Federation of the Laboratory Medicine Working Group on test evaluation in 2017 and a member of the Board of Directors of the Foundation Toscana Gabriele Monasterio for Medical Research and Public Health, based in Pisa, in 2012. Her research interests include the development of methodologies for the separation and identification of biomolecules, the investigation of the functional and morphological changes occurring in muscle in several physiological and pathological states, the development of (1) clinical methods for the monitoring of drugs; (2) protocols for serological profiles for the clinical diagnosis of pancreatic and prostate cancer; (3) MALDI imaging methodologies for monitoring nanoparticles; (4) HPTLC-MALDI methodologies for the recognition and quantitation of gangliosides and globosides in tissue extracts.